Author:
Riyaten Prakit,Salvadori Nicolas,Traisathit Patrinee,Ngo-Giang-Huong Nicole,Cressey Tim R.,Leenasirimakul Prattana,Techapornroong Malee,Bowonwatanuwong Chureeratana,Kantipong Pacharee,Nilmanat Ampaipith,Yutthakasemsunt Naruepon,Chutanunta Apichat,Thongpaen Suchart,Klinbuayaem Virat,Decker Luc,Le Cœur Sophie,Lallemant Marc,Capeau Jacqueline,Mary Jean-Yves,Jourdain Gonzague
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference22 articles.
1. . Protease inhibitor-associated hyperglycaemia.;Dube;Lancet,1997
2. Severe diabetes associated with protease inhibitor therapy.;Visnegarwala;Ann Intern Med,1997
3. . A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.;Carr;AIDS,1998
4. . Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.;Carr;Lancet,1999
5. Diabetes, insulin resistance, and HIV.;Hadigan;Curr Infect Dis Rep,2006